How many email patterns does Marinomed Biotech AG use?

Marinomed Biotech AG uses 4 known email patterns.

What domain does Marinomed Biotech AG use for work emails?

Marinomed Biotech AG uses marinomed.com for work email addresses.

Most Common Email Formats at Marinomed Biotech AG

Marinomed Biotech AG's most common email format is First.Last@marinomed.com (ex. John.Doe@marinomed.com), used for 64% of marinomed.com addresses. Marinomed Biotech AG uses 3 email patterns.

@marinomed.com

3 patterns

Format	Example	Share of marinomed.com
First.Last@marinomed.comMost common	John.Doe@marinomed.com	64%
FLast@marinomed.com	JDoe@marinomed.com	32%
First@marinomed.com	John@marinomed.com	4%

Frequently Asked Questions

What does Marinomed Biotech AG do?

Marinomed Biotech AG was founded in 2006 and operates in the Biotechnology Research industry, alongside similar companies like BIOCAD, Nanomerics Ltd and Generex Biotechnology Corporation. You can visit marinomed.com. Explore Marinomed Biotech AG's company overview page for more information.

What is Marinomed Biotech AG's email address format?

Marinomed Biotech AG's email format typically follows the pattern of First.Last@marinomed.com; this email format is used 64% of the time. Other contacts within LeadIQ's database had email formats such as FLast@marinomed.com and First@marinomed.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Marinomed Biotech AG have currently?

Marinomed Biotech AG has approximately 34 employees as of November 2026. Key team members to contact include Chief Executive Officer: A. G., Cso: E. P. and Chief Financial Officer: G. R. For more team information and contact data, explore Marinomed Biotech AG's employee directory with LeadIQ.

Marinomed Biotech AG Email Format

Biotechnology ResearchWien, Austria11-50 Employees

Marinomed Biotech AG is a small- to mid-sized Austrian biotech company based in Korneuburg, Niederösterreich, focused on developing therapies for respiratory and ophthalmic diseases, anchored by its Marinosolv technology. The platform enhances the solubility and bioavailability of poorly soluble compounds, enabling the creation of novel treatments for immune-related and inflammatory conditions, with some products marketed internationally. The firm maintains a growing development pipeline and operates within the global biotech landscape. In 2025, its Carragelose-based OTC business was sold to Unither Pharmaceuticals as part of a portfolio realignment. In May 2026, Marinomed announced a term sheet with Phargentis SA to jointly develop a respiratory therapeutic using Marinosolv, with the company providing specialized formulation services and technical expertise. The business is publicly listed on the Vienna Stock Exchange (VSE:MARI).

Most Common Email Formats at Marinomed Biotech AG

@marinomed.com

Need a specific person's email?

Frequently Asked Questions

What does Marinomed Biotech AG do?

What is Marinomed Biotech AG's email address format?

How many employees does Marinomed Biotech AG have currently?

Marinomed Biotech AG Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at Marinomed Biotech AG

@marinomed.com

Need a specific person's email?

Frequently Asked Questions

What does Marinomed Biotech AG do?

What is Marinomed Biotech AG's email address format?

How many employees does Marinomed Biotech AG have currently?

Marinomed Biotech AG Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.